Nexus Faces Five Year Wait On Injectable Minocycline

Federal Circuit Upholds Infringement And Validity Of Reformulated Minocin Patent, Keeping Generic Out Until 2031

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.